Harvesting the Low-Hanging Fruit: Kinase Inhibitors for Therapy of Advanced Medullary and Nonmedullary Thyroid Cancer
Author:
Affiliation:
1. Human Oncology and Pathogenesis Program (J.A.F.), Memorial Sloan-Kettering Cancer Center, New York, New York 10065
2. Department of Medicine (J.A.F., R.M.T., D.G.P.), Memorial Sloan-Kettering Cancer Center, New York, New York 10065
Publisher
The Endocrine Society
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Link
http://academic.oup.com/jcem/article-pdf/95/6/2621/9066933/jcem2621.pdf
Reference29 articles.
1. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;J Clin Endocrinol Metab,2006
2. Refractory thyroid cancer: a paradigm shift in treatment is not far off;Pfister;J Clin Oncol,2008
3. Phase II trial of sorafenib in advanced thyroid cancer;Gupta-Abramson;J Clin Oncol,2008
4. Motesanib diphosphate in progressive differentiated thyroid cancer;Sherman;N Engl J Med,2008
5. Phase II trial of sorafenib in metastatic thyroid cancer;Kloos;J Clin Oncol,2009
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thyroid Cancer: From Genes to Treatment – Recent Developments;Thyroid Cancer - The Road From Genes to Successful Treatment;2023-07-19
2. Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR;European Journal of Cancer;2021-11
3. Familial thyroid carcinoma: the road less traveled in thyroid pathology – an update;Diagnostic Histopathology;2017-08
4. Molecular diagnostics and anaplastic thyroid carcinoma: the time has come to harvest the high hanging fruit;International Journal of Endocrine Oncology;2016-08
5. The treatment landscape in thyroid cancer: a focus on cabozantinib;Cancer Management and Research;2015-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3